AI Article Synopsis

  • Acute symptomatic seizures (ASS) are a type of seizure linked to immediate brain damage caused by various factors like infection, inflammation, or metabolic issues, distinguishing them from true epileptic seizures.
  • ASS may appear similar to epileptic seizures during an episode, leading to challenges in diagnosis and treatment, but they require different approaches based on their underlying causes.
  • Treatment for ASS focuses on two goals: stopping the current seizures and addressing the underlying factors to prevent future seizures, which may involve long-term antiepileptic medication if there's a continued risk.

Article Abstract

Acute symptomatic seizures (ASS) are the seizures of different etiology that occur in close temporary relationship to acute damage of the central nervous system arising simultaneously due to metabolic, toxic, infectious and inflammatory factors and structural brain damage. At the time of its origin, ASS is often not distinguished from epileptic seizures in the clinical and electrophysiological parameters, although represent a fundamentally different state from the point of view of pathogenesis, therapy and prognosis. Tactics in the ASS and symptomatic epileptic status of any nature provides for the immediate carrying out differential diagnosis and differential treatment. Treatment of ASS includes two aspects: reduction in ictal activity (seizures) and prevention of future development of seizures through the elimination or correction of physiological trigger of the attacks and the decision to conduct a long-term antiepileptic drug therapy if the risk of seizures is saved.

Download full-text PDF

Source
http://dx.doi.org/10.17116/jnevro20151154124-29DOI Listing

Publication Analysis

Top Keywords

symptomatic epileptic
8
epileptic seizures
8
seizures
7
[acute symptomatic
4
seizures status
4
status epilepticus]
4
epilepticus] acute
4
acute symptomatic
4
symptomatic seizures
4
ass
4

Similar Publications

Engineered tRNAs efficiently suppress CDKL5 premature termination codons.

Sci Rep

December 2024

Department of Medical Biotechnology and Translational Medicine, University of Milan, Segrate (Milan), 20054, Italy.

The CDKL5 deficiency disorder (CDD) is a severe neurodevelopmental disorder characterized by early-onset epilepsy, intellectual disability, motor and visual dysfunctions. The causative gene is CDKL5, which codes for a kinase required for brain development. There is no cure for CDD patients; treatments are symptomatic and focus mainly on seizure control.

View Article and Find Full Text PDF

Epileptic seizures, which are often accompanied by a reduction in vigilance, are a common emergency. Every first-time epileptic seizure should be investigated further. Particular attention should be paid to whether it is an acute symptomatic seizure, which is an acute event characterized by a metabolic disorder or acute cerebral damage within a certain period of time, or possibly epilepsy.

View Article and Find Full Text PDF

Inherited metabolic epilepsies-established diseases, new approaches.

Epilepsia Open

December 2024

Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity. These characteristics make it particularly challenging to establish their targeted therapies, and many of the IMEs are treated nowadays only symptomatically and supportively.

View Article and Find Full Text PDF

Early neonatal seizures have myriad causes and variable prognoses. While acute symptomatic seizures are the most common events, a significant number of cases have a genetic background for such seizures, and a timely diagnosis can help in appropriate management and prognostication. We present a case of a neonate referred to our center with multi-focal clonic seizure starting from the first day of life.

View Article and Find Full Text PDF

Maple syrup urine disease (MSUD) is an inborn error of metabolism characterized by the accumulation of branched-chain amino acids (leucine, isoleucine, and valine) caused by a defect in the branched-chain alpha-keto acid dehydrogenase complex. Liver transplant is an effective therapy for MSUD, and patients can usually tolerate a regular diet after transplant without symptomatic metabolic decompensation. Most post-transplant patients do not follow a sick-day diet.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!